October 7, 2025 – The ATA announces with pleasure that M. Regina Castro, MD, a…
Read More
Drs Kaniksha Desai and Julie Ann Sosa discuss the 2025 American Thyroid Association guidelines for…
From Medscape® Diabetes & Endocrinology Coverage from the American Thyroid Association® (ATA) 2025 Meeting Can…
Hypothyroidism is a common endocrine problem affecting mostly women. If untreated, it leads to impaired quality of life and function. The standard therapy for hypothyroidism, as recommended by the American Thyroid Association® (ATA), is synthetic levothyroxine, a safe and effective therapy. The US Food and Drug Administration (FDA) regulates levothyroxine medications to ensure bioavailability, dose equivalence, potency, and purity.
September 11, 2025 – The American Thyroid Association® is delighted to recognize W. Edward Visser,…
From Clinical Thyroidology® for the Public: Disorders of the thyroid, including autoimmune disorders, can develop…
Over the past decade, molecular diagnostics have transformed how we assess cancer risks, help avoid unnecessary surgeries, and make personalized treatment decisions. In this episode, we’ll discuss the evolution of the molecular testing, review commonly used platforms, and explore how to apply the results effectively in clinical practice.
From Clinical Thyroidology® for the Public: Some patients with Graves’ disease develop thyroid eye disease,…
From Clinical Thyroidology® for the Public: GLP1 receptor agonists (GLP1-RAs) are popular medications that are…
From Clinical Thyroidology® for the Public: TSH and FT4 tests are commonly ordered to evaluate…
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.